Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03779035
What this trial is testing

Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection

Who this might be right for
CholangiocarcinomaGall Bladder Carcinoma
Tianjin Medical University Cancer Institute and Hospital 460
Large-scale testing (Phase 3)UnknownNCT00047138
What this trial is testing

Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor

Who this might be right for
Kidney Cancer
University of Leicester 350
Large-scale testing (Phase 3)UnknownNCT06031597
What this trial is testing

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Who this might be right for
Non-small Cell Lung Cancer Stage III
Zhejiang Cancer Hospital 105
Post-approval studies (Phase 4)UnknownNCT01336192
What this trial is testing

Maintenance Gemcitabine in the Chinese Advanced Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Tongji University 240
Early research (Phase 1)Study completedNCT02260544
What this trial is testing

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection

Who this might be right for
Ovarian Epithelial Cancer Recurrent
Dr. Reddy's Laboratories Limited 49
Large-scale testing (Phase 3)UnknownNCT03709316
What this trial is testing

ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Zai Lab (Shanghai) Co., Ltd. 384
Testing effectiveness (Phase 2)Study completedNCT04997382
What this trial is testing

Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 112
Large-scale testing (Phase 3)UnknownNCT00657878
What this trial is testing

Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval

Who this might be right for
Ovarian Cancer
National Cancer Institute, Naples 215
Not applicableUnknownNCT03878017
What this trial is testing

A Novel Method of Clipped Axillary Lymph Node Localization Post Neoadjuvant Chemotherapy in Breast Cancer Patients .

Who this might be right for
Breast Cancer Female
KK Women's and Children's Hospital 15
Large-scale testing (Phase 3)Study completedNCT00003010
What this trial is testing

Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group 334
Large-scale testing (Phase 3)UnknownNCT01917578
What this trial is testing

Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 4
Large-scale testing (Phase 3)Looking for participantsNCT06509724
What this trial is testing

Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy

Who this might be right for
Uterine Cervical Neoplasms
Samsung Medical Center 248
Testing effectiveness (Phase 2)UnknownNCT01002703
What this trial is testing

Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leipzig 50
Very early researchUnknownNCT04130750
What this trial is testing

Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice

Who this might be right for
Breast CancerNeoadjuvant ChemotherapyDrug Effect
Peking University People's Hospital 200
Testing effectiveness (Phase 2)UnknownNCT03983759
What this trial is testing

Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerExtensive DiseaseAdoptive Cellular Immunotherapy+2 more
Henan Cancer Hospital 40
Large-scale testing (Phase 3)UnknownNCT05536596
What this trial is testing

Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy

Who this might be right for
RetrognathismPrognathismOrthognathic Surgery+1 more
Universitat Internacional de Catalunya 220
Testing effectiveness (Phase 2)Ended earlyNCT04352413
What this trial is testing

PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy

Who this might be right for
Small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 45
Testing effectiveness (Phase 2)UnknownNCT01170923
What this trial is testing

FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Asan Medical Center 100
Post-approval studies (Phase 4)Study completedNCT03937713
What this trial is testing

Effectiveness of Combining Behavioral and Pharmacologic Therapy for Complex Insomnia in Veterans With PTSD

Who this might be right for
Complex Insomnia
VA Office of Research and Development 53
Testing effectiveness (Phase 2)WithdrawnNCT05614453
What this trial is testing

Tislelizumab in Combination With Sitravatinib for Recurrent/Metastatic Cervical Cancer After Platinum-Based Chemotherapy

Who this might be right for
Metastatic Cervical Cancer
Australia New Zealand Gynaecological Oncology Group
Next Page